非出血性解離性脳動脈りゅうの治療方針 椎骨脳底動脈系の非出血性解離性動脈病変の治療方針
スポンサーリンク
概要
- 論文の詳細を見る
Intracranial arterial dissection is considered to be not a rare disease recently, but the natural history of this disease is not well known yet. In this study, we analyzed the serial changes of angiographical or MRI/MRA finding and the long-term outcome to clarify the treatment strategy in patients with non-hemorrhagic intracranial arterial dissection. Among 120 consecutive patients with arterial dissection of the vertebrobasilar system, 44 (37%) presented with ischemia and/or headache. Ages ranged from 27 to 77 years (mean: 49.3+/-11.0 years). Thirty-nine patients were managed conservatively and an antiplatelet agent was given in 10 because of history of myocardial or brain ischemia. Only 5 were treated surgically because the lesion had been enlarged or extended on the follow-up study. The vertebral artery was most commonly affected. On the initial angiographical or MRI/MRA finding, fusiform dilatation (43%) was the most frequent finding, followed by pearl and string sign (32%). In the serial changes of the findings, no change (43%) was most common, followed by improvement (37%). Among 39 patients who presented with ischemia, 8 (21%) had subsequent symptoms (ischemia in 7, subarachnoid hemorrhage in 1). Recurrence tended to occur more frequently in the antiplatelet group. The follow-up period ranged from 1 to 17 years (mean: 5.8+/-4.1 years). The long-term outcomes were generally favorable. Thirty-three patients (85%) recovered well and 3 died among the 39 conservatively managed patients. Four of 5 patients achieved good recovery and returned to work in the surgically treated group. In addition, the outcomes in the antiplatelet group did not differ significantly from those without the above agents. These results were quite similar to those in the nationwide study, and suggest that conservative treatment, mainly the control of high blood pressure, is the first choice in the non-hemorrhagic arterial dissection of the vertebrobasilar system and that antiplatelet or anticoagulant therapy might not be indicated in the patient with ischemia. Furthermore, the surgical indication for this disease remains controversial, and the study of a larger number of patients is indispensable to clarify this issue.
- 一般社団法人 日本脳卒中の外科学会の論文
一般社団法人 日本脳卒中の外科学会 | 論文
- 頸部内頸動脈のｎｅａｒ ｏｃｃｌｕｓｉｏｎに対するＳＴＡ‐ＭＣＡ吻合術
- 未破裂脳動脈瘤の外科手術の合併症とその対策―慢性硬膜下血腫および後頭蓋窩出血の発生予防―:―慢性硬膜下血腫および後頭蓋窩出血の発生予防―
- 周術期管理指針に基づいたもやもや病に対する血行再建術:―急性期脳血流評価と予防的降圧の効果と限界―
- 未破裂脳動脈瘤クリッピング術の治療成績‐脳動脈瘤手術初心者の経験‐:―脳動脈瘤手術初心者の経験―
- 脳底動脈上小脳動脈分岐部動脈りゅう５８手術例の検討